MetLife Investment Management
OCGN icon

MetLife Investment Management’s Ocugen OCGN Stock Holding History

MetLife Investment Management’s Portfolio OCGN Stock Details OCGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$308K Buy
+201,464
New +$306K ﹤0.01% 2194
2025
Q2 		– Sell
-44,769
Closed -$31.6K – 2900
2025
Q1 		$31.6K Sell
44,769
-125,687
-74% -$86.9K ﹤0.01% 2726
2024
Q4 		$137K Buy
170,456
+80,948
+90% +$74.1K ﹤0.01% 2482
2024
Q3 		$88.8K Buy
89,508
+23,877
+36% +$32.8K ﹤0.01% 2669
2024
Q2 		$102K Buy
+65,631
New +$102K ﹤0.01% 2595
2023
Q2 		– Sell
-116,226
Closed -$99.2K – 2974
2023
Q1 		$99.2K Buy
116,226
+45,303
+64% +$49.4K ﹤0.01% 2558
2022
Q4 		$92.2K Sell
70,923
-41,609
-37% -$64.9K ﹤0.01% 2624
2022
Q3 		$200K Hold
112,532
– – ﹤0.01% 2304
2022
Q2 		$255K Buy
112,532
+45,026
+67% +$108K ﹤0.01% 2140
2022
Q1 		$223K Buy
67,506
+1,523
+2% +$5.35K ﹤0.01% 2288
2021
Q4 		$300K Buy
65,983
+9,087
+16% +$68.6K ﹤0.01% 1811
2021
Q3 		$409K Sell
56,896
-10,891
-16% -$79.9K ﹤0.01% 1644
2021
Q2 		$544K Buy
+67,787
New +$572K ﹤0.01% 1518

Other funds holding OCGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

MetLife Investment Management's OCGN Position: Q2 2026 in Review

MetLife Investment Management opened a new position in Ocugen (OCGN) in Q2 2026: 201,464 shares worth $308K. The stake represents ﹤0.01% of the portfolio and ranks #2194 among its holdings. This is a return to the name: MetLife Investment Management previously reported a position in OCGN as recently as Q1 2025.

MetLife Investment Management first reported a position in OCGN in Q2 2021 and has held it in 13 quarters since. The position peaked at $544K in Q2 2021. 147 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

  • MetLife Investment Management held 201,464 shares of Ocugen worth $308K as of Q2 2026.
  • Ocugen was a new MetLife Investment Management position in Q2 2026.
  • Ocugen made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2194 holding.
  • MetLife Investment Management first reported a position in Ocugen in Q2 2021 and has held it in 13 quarters since.
  • MetLife Investment Management's Ocugen position peaked at $544K in Q2 2021.
  • 147 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.